Roche's Genentech to invest $750 million in Oregon manufacturing expansion

Genentech, a subsidiary of Roche, is doubling the capacity of its production facility in Hillsboro, Oregon, with a $750 million capital investment. This expansion aims to bolster domestic biopharmaceutical manufacturing capabilities, though specific product lines for the new capacity remain undisclosed.